Home
Live Updates
Biocon Biologics gains FDA approval for Yesafili, shares up : comparemela.com
Biocon Biologics gains FDA approval for Yesafili, shares up
Biocon Biologics secures FDA approval for Yesafili, an interchangeable biosimilar to Eylea, for ophthalmological conditions. Launch in Canada set.
Related Keywords
United States ,
Canada ,
United Kingdom ,
Shreehas Tambe ,
Biocon Biologics ,
Twitter ,
Biocon Ltd ,
Biocon ,
Biocon Biologics Ltd ,
Facebook ,
Linkedin ,
comparemela.com © 2020. All Rights Reserved.